Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
2.640
-0.100 (-3.65%)
At close: Oct 29, 2024, 4:00 PM
2.720
+0.080 (3.03%)
After-hours: Oct 29, 2024, 7:42 PM EDT

Inhibikase Therapeutics Market Cap

Inhibikase Therapeutics has a market cap or net worth of $177.39 million as of October 29, 2024. Its market cap has increased by 3,447.77% in one year.

Market Cap
177.39M
Enterprise Value
169.80M
1-Year Change
3,447.77%
Ranking
Category
Stock Price
$2.64

Market Cap Chart

Since the IPO on December 23, 2020, Inhibikase Therapeutics's market cap has increased from $100.46M to $177.39M, an increase of 76.58%. That is a compound annual growth rate of 15.92%.

History

DateMarket Cap% Change
Oct 28, 202420.50M162.82%
Dec 29, 20237.80M-38.10%
Dec 30, 202212.60M-65.95%
Dec 31, 202137.00M-44.19%
Dec 31, 202066.30M-34.00%
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition